Chinese english Germany Japanese Korea

Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]-

Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]- Struktur
151945-42-5
CAS-Nr.
151945-42-5
Englisch Name:
Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]-
Synonyma:
Rapamycin Impurity 37;1-Pyrrolidinepropanol,α-cyclohexyl-α-(4-methoxyphenyl)-β-phenyl-;Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,...;Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]-
CBNumber:
CB612163511
Summenformel:
C51H79NO13
Molgewicht:
914.17
MOL-Datei:
Mol file
Request For Quotation

Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]- Eigenschaften

Siedepunkt:
992.2±65.0 °C(Predicted)
Dichte
1.19±0.1 g/cm3(Predicted)
pka
10.46±0.20(Predicted)

Sicherheit

Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]- Chemische Eigenschaften,Einsatz,Produktion Methoden

Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
 greensnown@163.com China 9911 50
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
 3003392093@qq.com China 8041 55
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 18162595016
 3287908757@qq.com China 9887 58
  • Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]-
  • Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,...
  • Rapamycin Impurity 37
  • 1-Pyrrolidinepropanol,α-cyclohexyl-α-(4-methoxyphenyl)-β-phenyl-
  • 151945-42-5
Copyright 2019 © ChemicalBook. All rights reserved